During the past decade, Phoenix Heart, PLLC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoenix Heart, PLLC" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoenix Heart, PLLC" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Northwestern University" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Roche Diagnostics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Phoenix Heart, PLLC" are "Cardiovascular Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Left Ventricular Dysfunction" (2 trials), "CRT-D Cardiac Resynchronization Therapy Defibrillator" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Phoenix Heart, PLLC" in a lesser frequency.

Most popular intervention types in "Phoenix Heart, PLLC" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "CRT-D" (1 trials), "Lorcaserin hydrochloride" (1 trials) and "REVEAL Implantable Cardiac Monitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phoenix Heart, PLLC" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Phoenix Heart, PLLC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Phoenix Heart, PLLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Phoenix Heart, PLLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".